VIVE — Viveve Medical Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$0.28m
- $6.43m
Annual cashflow statement for Viveve Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -37 | -50 | -42.5 | -21.9 | -22 |
| Depreciation | |||||
| Non-Cash Items | 2.96 | 5.71 | 12.4 | 5.88 | 3.89 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.3 | 0.398 | -2.34 | -0.497 | 4.13 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -34.9 | -43.1 | -31.2 | -15.2 | -12.9 |
| Capital Expenditures | -0.905 | -2.14 | -1.09 | -0.781 | -0.456 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.5 | 0 | — | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -3.4 | -2.14 | -1.09 | -0.781 | -0.456 |
| Financing Cash Flow Items | — | — | -0.222 | -0.861 | -0.07 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 50.9 | 54 | 16.1 | 9.23 | 26 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 12.6 | 8.79 | -16.2 | -6.79 | 12.6 |